C71.2
Malignant neoplasm of temporal lobe
Clinical Classification Guidelines
Medical Intelligence & Overview
A malignant neoplasm of the temporal lobe refers to a type of brain tumor that originates in the temporal part of the brain. These tumors are classified as cancerous and have the potential to grow rapidly, invade surrounding tissues, and spread to other parts of the brain or body. The temporal lobe plays a critical role in processing auditory information, memory, and speech comprehension, making tumors in this area particularly impactful. The ICD-10 code C71.2 is used by healthcare providers to identify and classify this specific malignancy for medical records and insurance purposes.
Causes & Symptoms
Clinical Causes: Genetic mutations or alterations in brain cells Exposure to radiation or carcinogenic chemicals Family history of brain tumors Previous head injuries or radiation therapy to the head Certain hereditary syndromes that increase cancer risk
Key Symptoms: Persistent headaches, often worsening over time Seizures or convulsions Memory loss or difficulty retaining new information Changes in personality, behavior, or mental state Auditory hallucinations or disturbances Weakness or numbness in parts of the face or limbs Speech difficulties or language problems Visual disturbances such as blurred vision or loss of peripheral vision
Diagnostic & Treatment
Diagnosis Path: Diagnosing a malignant neoplasm of the temporal lobe involves multiple steps, including imaging tests and biopsies. Procedures typically include: - Magnetic Resonance Imaging (MRI): This imaging technique provides detailed pictures of the brain and helps locate tumors, determine their size, and assess their spread. - Computed Tomography (CT) scan: Often used initially to detect abnormalities. - Biopsy: A sample of the tumor tissue is obtained through surgery or needle aspiration to confirm malignancy and identify tumor type. - Additional tests: These may include neurological examinations, EEG, or advanced imaging to evaluate tumor effects and plan treatment. Accurate diagnosis is crucial for effective management and treatment planning.
Treatment Protocols: Treatment strategies for malignant neoplasm of the temporal lobe are tailored to the individual patient, considering tumor size, location, and overall health. Common approaches include: - Surgery: Surgical removal of as much of the tumor as possible is often the first step to alleviate symptoms and reduce tumor burden. - Radiation therapy: Targeted radiation is used to destroy remaining cancer cells or shrink the tumor before or after surgery. - Chemotherapy: Anti-cancer medications may be administered systemically or directly to the tumor site to inhibit tumor growth. - Targeted therapy and immunotherapy: Emerging treatments that focus on specific molecular pathways involved in tumor growth. - Supportive and palliative care: Managing symptoms and improving quality of life throughout treatment. A multidisciplinary team of specialists collaborates to develop the most appropriate treatment plan for each patient.
Clinical Advice & FAQs
Billing Guidance
Is C71.2 a billable ICD-10 code?
Yes, C71.2 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C71.2?
Clinical documentation must specify the nature of Malignant neoplasm of temporal lobe and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
